Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2025 Sep;174(2):439-448.
doi: 10.1007/s11060-025-05075-0. Epub 2025 May 23.

Reconsideration of the resection strategy of eloquent brain metastasis in the era of postoperative stereotactic radiotherapy: a comparative analysis with non-eloquent metastasis

Affiliations
Comparative Study

Reconsideration of the resection strategy of eloquent brain metastasis in the era of postoperative stereotactic radiotherapy: a comparative analysis with non-eloquent metastasis

Levin Häni et al. J Neurooncol. 2025 Sep.

Abstract

Purpose: To decrease the recurrence rate after complete resection of a brain metastasis, removal of a surgical safety margin is advocated. This is not always feasible when resecting a metastasis in an eloquent location. We aimed to assess the recurrence rate after resection of metastases in an eloquent location followed by postoperative stereotactic radiotherapy to the resection cavity.

Methods: We retrospectively included patients with 1-3 brain metastases undergoing gross total resection and postoperative stereotactic radiotherapy between 2010 and 2022. Primary endpoint was local recurrence free survival (LRFS). Secondary endpoints were overall survival and distant brain failure free survival. Patients were grouped according to the location of their metastasis into eloquent and non-eloquent. Eloquent localization was considered a surrogate for resection without a surgical safety margin according to our institutional practice.

Results: We included 193 patients with 201 resected metastases. Ninety-five metastases (47.3%) were classified as eloquent and 106 (52.7%) as non-eloquent. Kaplan-Meier analysis showed no difference in LRFS between eloquent and non-eloquent metastases (HR 0.821, 95%-CI 0.447-1.507, p = 0.523). Only increased preoperative tumor volume was associated with worse LRFS (HR 1.015, 95% CI 1.001-1.028, p = 0.033). There was no difference concerning secondary endpoints between eloquent and non-eloquent metastases.

Conclusion: Omission of a surgical safety margin in at least a part of the resection cavity due to eloquence of adjacent tissue had no detrimental effect on local control after resection and postoperative stereotactic radiotherapy of a brain metastasis. This could influence the strategy during resection of an eloquent metastasis.

Keywords: Brain metastasis; Eloquence; Radiosurgery; Resection; Stereotactic radiotherapy; Surgical margin.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Resection of eloquent and non-eloquent metastases. Axial T1-weighted MR images with contrast are displayed with eloquent (A and B) and non-eloquent (C and D) metastasis. Eloquent metastases (A) were resected without a safety margin, resulting in a proportionally smaller postoperative resection cavity (B). In contrast, non-eloquent metastases (C) were resected with an additional safety margin, resulting in a larger resection cavity (D)
Fig. 2
Fig. 2
Study flow chart
Fig. 3
Fig. 3
Kaplan–Meier analysis of the primary outcome. Kaplan–Meier analysis of local recurrence free survival found no difference between eloquent and non-eloquent metastases after resection and postoperative SRS/SFRT (p = 0.523)

References

    1. Ostrom QT, Wright CH, Barnholtz-Sloan JS (2018) Brain metastases: epidemiology. Handb Clin Neurol 149:27–42. 10.1016/B978-0-12-811161-1.00002-5 - PubMed
    1. Patchell RA, Tibbs PA, Walsh JW et al (1990) A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322(8):494–500. 10.1056/NEJM199002223220802 - PubMed
    1. Patchell RA, Tibbs PA, Regine WF et al (1998) Postoperative radiotherapy in the treatment of single metastases to the brain. Jama. 10.1001/jama.280.17.1485 - PubMed
    1. Bindal RK, Sawaya R, Leavens ME, Lee JJ (1993) Surgical treatment of multiple brain metastases. J Neurosurg 79(2):210–216. 10.3171/jns.1993.79.2.0210 - PubMed
    1. Berghoff AS, Rajky O, Winkler F et al (2013) Invasion patterns in brain metastases of solid cancers. Neuro Oncol 15(12):1664–1672. 10.1093/neuonc/not112 - PMC - PubMed

Publication types